Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors
Clinical trial NCT02450123 · COMPLETED
Trial details
- NCT number
- NCT02450123
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2019-08-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.